Delisting risk
Plus Therapeutics (PSTV)
Develops targeted radiotherapeutics and CNSide diagnostics for central nervous system cancers.
$3.87
At close−0.13 (−3.25%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions22 holders · as of Jun 30, 2026 | ≥ 8.30% | 630.1K shares | |
| Insiders9 holders · as of Jul 1, 2026 | 0.90% | 68.2K shares | |
| Strategic holders1 holder · as of Aug 28, 2018 | 0.00% | 20 shares | |
| Otherremainder | ≤ 90.80% | 6.89M shares |
7.59M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (7.59M in the company's Sep 3, 2026 report, 2.42M elsewhere); stakes use the report.
Institutional filings for CNSY (100% of the company) are not on file here, so the institutional figure is a floor.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Jun 30, 2026
22 holders · 630.1K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 304.7K | 4.02% | Aug 13, 2026 | |
| BlackRock, Inc. | 96.0K | 1.26% | Aug 7, 2026 | |
| Geode Capital Management, LLC | 76.2K | 1.00% | Aug 12, 2026 | |
| Vanguard Fiduciary Trust Co | 36.9K | 0.49% | Aug 13, 2026 | |
| Ashton Thomas Private Wealth, LLC | 34.3K | 0.45% | Jul 29, 2026 | |
| Citadel Advisors LLC | 25.6K | 0.34% | Aug 14, 2026 | |
| Northern Trust Corp | 15.5K | 0.20% | Aug 13, 2026 | |
| Virtu Financial LLC | 15.3K | 0.20% | Aug 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 7.10% | 13G | May 15, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Nov 4, 2025 | Andrew John Hugh MacIntyre Simsofficer: Chief Financial Officer | Purchase | 20,000 | $0.5100 | 68,138 |
CongressHouse and Senate disclosures
Not reported.